Assessment of the effects of renal impairment on the pharmacokinetics of the soluble guanylate cyclase activator cinaciguat after a single intravenous dose
Lettieri, John T, Scheerans, Christian, Blunck, Martin, Mazzu, Arthur L, Frey, Reiner, Mück, Wolfgang, Sundaresan, Pavur R
Published in Journal of clinical pharmacology (01.08.2012)
Published in Journal of clinical pharmacology (01.08.2012)
Get more information
Journal Article
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
Tolcher, Anthony W., Appleman, Leonard J., Shapiro, Geoffrey I., Mita, Alain C., Cihon, Frank, Mazzu, Arthur, Sundaresan, Pavur R.
Published in Cancer chemotherapy and pharmacology (01.04.2011)
Published in Cancer chemotherapy and pharmacology (01.04.2011)
Get full text
Journal Article
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease
Thadani, Udho, Smith, William, Nash, Stephen, Bittar, Neville, Glasser, Stephen, Narayan, Puneet, Stein, Richard A, Larkin, Sharon, Mazzu, Arthur, Tota, Robert, Pomerantz, Kenneth, Sundaresan, Pavur
Published in Journal of the American College of Cardiology (04.12.2002)
Published in Journal of the American College of Cardiology (04.12.2002)
Get full text
Journal Article
Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction
Rajagopalan, Prabhu, Mazzu, Arthur, Xia, Chenghua, Dawkins, Ray, Sundaresan, Pavur
Published in Journal of clinical pharmacology (01.03.2003)
Published in Journal of clinical pharmacology (01.03.2003)
Get more information
Journal Article
Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia
Auerbach, Stephen M., Gittelman, Marc, Mazzu, Arthur, Cihon, Frank, Sundaresan, Pavur, White, William B.
Published in Urology (Ridgewood, N.J.) (01.11.2004)
Published in Urology (Ridgewood, N.J.) (01.11.2004)
Get full text
Journal Article
The effect of vardenafil, a selective PDE5 inhibitor, on ischemic threshold, exercise tolerance, and circulatory responses during treadmill exercise in men with stable angina pectoris
Thadani, Udho, Chrysant, Steven, Mazzu, Arthur
Published in Journal of the American College of Cardiology (19.03.2003)
Published in Journal of the American College of Cardiology (19.03.2003)
Get full text
Journal Article
Nickel peroxide dehydrogenation of oxygen-, sulfur-, and nitrogen-containing heterocycles
Evans, David L, Minster, David K, Jordis, Ulrich, Hecht, Sidney M, Mazzu, Arthur L, Meyers, A. I
Published in Journal of organic chemistry (01.02.1979)
Published in Journal of organic chemistry (01.02.1979)
Get full text
Journal Article
Coadministered vardenafil (for erectile dysfunction) and tamsulosin do not induce hypotension in patients with benign prostatic hypertrophy
Auerback, Stephen, Gittelman, Marc, Mazzu, Arthur, Sundaresan, P.R., White, William B.
Published in American journal of hypertension (01.05.2004)
Published in American journal of hypertension (01.05.2004)
Get full text
Journal Article
OR 35: Coadministered vardenafil (for erectile dysfunction) and tamsulosin do not induce hypotension in patients with benign prostatic hypertrophy
Auerback, Stephen, Gittelman, Marc, Mazzu, Arthur, Sundaresan, P.R., White, William B.
Published in American journal of hypertension (01.05.2004)
Published in American journal of hypertension (01.05.2004)
Get full text
Journal Article
Intramolecular cycloaddition reactions of vinyl azides bearing alkenyl and alkynyl groups
Padwa, Albert, Ku, Audrey, Ku, Hao, Mazzu, Arthur
Published in Journal of organic chemistry (01.01.1978)
Published in Journal of organic chemistry (01.01.1978)
Get full text
Journal Article
Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Commentary
AUERBACH, Stephen M, GITTELMAN, Marc, MAZZU, Arthur, CIHON, Frank, SUNDARESAN, Pavur, WHITE, William B, TE, Alexis E
Published in Urology (Ridgewood, N.J.) (2004)
Get full text
Published in Urology (Ridgewood, N.J.) (2004)
Journal Article
The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: a double-blind, placebo-controlled trial in patients with esrd
Keane, W F, Brenner, B M, Mazzu, A, Agro, A
Published in American journal of kidney diseases (01.01.2001)
Published in American journal of kidney diseases (01.01.2001)
Get more information
Journal Article
Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
Stein, Evan, Isaacsohn, Jonathan, Stoltz, Randall, Mazzu, Arthur, Liu, Ming-Chung, Lane, Cindy, Heller, Allen H.
Published in The American journal of cardiology (15.05.1999)
Published in The American journal of cardiology (15.05.1999)
Get full text
Journal Article
Influence of age on the safety, tolerability, and pharmacokinetics of the novel HMG-CoA reductase inhibitor cerivastatin in healthy male volunteers
Mazzu, A, Lettieri, J, Kaiser, L, Mullican, W, Heller, A H
Published in Journal of clinical pharmacology (01.08.1998)
Published in Journal of clinical pharmacology (01.08.1998)
Get more information
Journal Article